<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Blogs | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/posts/blogs/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Tue, 27 Oct 2026 13:01:51 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Blogs | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Mayo Clinic: Cerebrospinal fluid liquid biopsy detects tumor DNA in complex brain cases</title>
		<link>https://tissuepathology.com/2026/10/27/mayo-clinic-cerebrospinal-fluid-liquid-biopsy-detects-tumor-dna-in-complex-brain-cases/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 27 Oct 2026 13:01:51 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Cerebrospinal fluid liquid biopsy]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Mayo Clinic]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[tumor DNA brain cancer]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24763</guid>

					<description><![CDATA[<p>A Mayo Clinic study published in the Journal of Neuro-Oncology suggests that analyzing DNA in cerebrospinal fluid could provide another source of information when MRI cannot provide a clear brain tumor diagnosis or obtaining tissue through biopsy is difficult or potentially unsafe. The study included 76 patients facing one of three challenging clinical scenarios: An [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/10/27/mayo-clinic-cerebrospinal-fluid-liquid-biopsy-detects-tumor-dna-in-complex-brain-cases/">Mayo Clinic: Cerebrospinal fluid liquid biopsy detects tumor DNA in complex brain cases</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proscia: How Unilabs is Advancing Digital Pathology and Precision Medicine with Proscia</title>
		<link>https://tissuepathology.com/2026/09/25/proscia-how-unilabs-is-advancing-digital-pathology-and-precision-medicine-with-proscia/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 25 Sep 2026 15:11:45 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[Proscia]]></category>
		<category><![CDATA[Unilabs]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24702</guid>

					<description><![CDATA[<p>From the Proscia blog: Every patient’s care journey starts with a diagnosis. As our understanding of disease becomes more nuanced, pathologists are expected to deliver increasingly specific answers. Meanwhile, their expertise is in short supply, and demand for diagnostic services continues to rise. Many laboratories are finding it harder to consistently provide the timely, informed [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/25/proscia-how-unilabs-is-advancing-digital-pathology-and-precision-medicine-with-proscia/">Proscia: How Unilabs is Advancing Digital Pathology and Precision Medicine with Proscia</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proscia: Freedom to Grow: Why an Open, Interoperable Platform Is Non-Negotiable for Digital Pathology</title>
		<link>https://tissuepathology.com/2026/09/18/proscia-freedom-to-grow-why-an-open-interoperable-platform-is-non-negotiable-for-digital-pathology/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 18 Sep 2026 13:50:28 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Interoperability]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Proscia]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24687</guid>

					<description><![CDATA[<p>From the Proscia blog: Interoperability remains a major barrier to the scaled adoption of digital pathology. Signify Research took this away from their recent discussions with seven pathologists and leaders across academic and health system laboratories. It’s also a concern we hear often in our own conversations with laboratory leaders. The challenge lies in the technology ecosystem [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/18/proscia-freedom-to-grow-why-an-open-interoperable-platform-is-non-negotiable-for-digital-pathology/">Proscia: Freedom to Grow: Why an Open, Interoperable Platform Is Non-Negotiable for Digital Pathology</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>FormaPath: Mecademic Showcases the Meca500 Powering FormaPath&#8217;s nToto</title>
		<link>https://tissuepathology.com/2026/08/31/formapath-mecademic-showcases-the-meca500-powering-formapaths-ntoto/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 31 Aug 2026 12:26:46 +0000</pubDate>
				<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Automation]]></category>
		<category><![CDATA[FormaPath]]></category>
		<category><![CDATA[Mecademic Industrial Robotics]]></category>
		<category><![CDATA[precision robotics]]></category>
		<category><![CDATA[small biopsy grossing]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24648</guid>

					<description><![CDATA[<p>From the FormaPath blog: FormaPath was honored to be featured by Mecademic Industrial Robotics, highlighting the integration of the Meca500 robotic arm within the nToto platform. By combining Mecademic&#8217;s micrometer-level precision robotics with FormaPath&#8217;s AI-driven automation, nToto delivers a fully automated workflow for small biopsy grossing, improving consistency, traceability, and laboratory efficiency. We&#8217;re proud of [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/08/31/formapath-mecademic-showcases-the-meca500-powering-formapaths-ntoto/">FormaPath: Mecademic Showcases the Meca500 Powering FormaPath’s nToto</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Gestalt: Why Healthcare IT Staff Augmentation Is Replacing Traditional Hiring in 2026</title>
		<link>https://tissuepathology.com/2026/08/24/gestalt-why-healthcare-it-staff-augmentation-is-replacing-traditional-hiring-in-2026/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 24 Aug 2026 12:37:51 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Jobs]]></category>
		<category><![CDATA[Laboratory Management & Operations]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Gestalt]]></category>
		<category><![CDATA[Healthcare IT]]></category>
		<category><![CDATA[Hiring]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24633</guid>

					<description><![CDATA[<p>From the Gestalt blog: Healthcare IT isn’t shrinking, it’s resetting. After the surge of pandemic-era hiring, many health systems are stepping back and asking a hard question: does more headcount actually make us more agile? In 2026, with tighter margins, AI initiatives accelerating, and cybersecurity demands rising, the answer often isn’t yes. Fixed labor costs can [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/08/24/gestalt-why-healthcare-it-staff-augmentation-is-replacing-traditional-hiring-in-2026/">Gestalt: Why Healthcare IT Staff Augmentation Is Replacing Traditional Hiring in 2026</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proscia: Getting to Know Kary Rogers: A Conversation with Proscia’s Head of Support</title>
		<link>https://tissuepathology.com/2026/08/21/proscia-getting-to-know-kary-rogers-a-conversation-with-proscias-head-of-support/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 21 Aug 2026 11:58:09 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Kary Rogers]]></category>
		<category><![CDATA[LinkedIn]]></category>
		<category><![CDATA[product support]]></category>
		<category><![CDATA[Proscia]]></category>
		<category><![CDATA[Software]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24630</guid>

					<description><![CDATA[<p>From Proscia on LinkedIn When evaluating an enterprise pathology platform, many life sciences organizations and diagnostic laboratories focus on the features it offers. This makes sense since scientists and pathologists will rely on that functionality every day. At Proscia, we believe that product functionality is one important part of the experience that we deliver to [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/08/21/proscia-getting-to-know-kary-rogers-a-conversation-with-proscias-head-of-support/">Proscia: Getting to Know Kary Rogers: A Conversation with Proscia’s Head of Support</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
